These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26805794)

  • 1. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies.
    Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M
    Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.
    Shrotriya SN; Ranpise NS; Vidhate BV
    Drug Deliv Transl Res; 2017 Feb; 7(1):37-52. PubMed ID: 27981502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
    Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
    AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
    Neves AR; Lúcio M; Martins S; Lima JL; Reis S
    Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
    Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
    Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
    Diab RF; Abdelghany TM; Gad S; Elbakry AM
    J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.
    Palliyage GH; Hussein N; Mimlitz M; Weeder C; Alnasser MHA; Singh S; Ekpenyong A; Tiwari AK; Chauhan H
    Pharm Res; 2021 May; 38(5):851-871. PubMed ID: 33982225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimization, and
    Nasiri F; Faghfouri L; Hamidi M
    Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713
    [No Abstract]   [Full Text] [Related]  

  • 12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design of naproxen solid lipid nanoparticles to target skin layers.
    Akbari J; Saeedi M; Morteza-Semnani K; Rostamkalaei SS; Asadi M; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():626-633. PubMed ID: 27288817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
    Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preformulation, Characterization, and
    Algul D; Duman G; Ozdemir S; Acar ET; Yener G
    J Cosmet Sci; 2018; 69(3):165-173. PubMed ID: 30052191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles.
    Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Gill P; Valizadeh H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2015 Apr; 128():473-479. PubMed ID: 25797482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
    Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
    Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.